Works matching IS 02698811 AND DT 2024 AND VI 38 AND IP 4

Results: 9

Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 324, doi. 10.1177/02698811241241384
By:
- da Rosa, André Luiz Schuh Teixeira;
- Bezerra, Olivia Sorato;
- Rohde, Luis Augusto;
- Graeff-Martins, Ana Soledade
Publication type:
Article
Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 353, doi. 10.1177/02698811241240308
By:
- Chang, Minna;
- Chang, Kai Tuomas;
- Chang, Fuju
Publication type:
Article
Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 318, doi. 10.1177/02698811241239596
By:
- Cortese, Samuele;
- Besag, Frank MC;
- Clark, Bruce;
- Hollis, Chris;
- Kilgariff, Joe;
- Moreno, Carmen;
- Nicholls, Dasha;
- Wilkinson, Paul;
- Woodbury-Smith, Marc;
- Sharma, Aditya
Publication type:
Article
Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 311, doi. 10.1177/02698811241239582
By:
- Cortese, Samuele;
- Besag, Frank MC;
- Clark, Bruce;
- Hollis, Chris;
- Kilgariff, Joe;
- Moreno, Carmen;
- Nicholls, Dasha;
- Wilkinson, Paul;
- Woodbury-Smith, Marc;
- Sharma, Aditya
Publication type:
Article
A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 344, doi. 10.1177/02698811241239543
By:
- O'Neill, James R.;
- Jameson, Adam;
- McLean, Samantha L.;
- Dixon, Michael;
- Cardno, Alastair G.;
- Lawrence, Christopher
Publication type:
Article
Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 375, doi. 10.1177/02698811241238284
By:
- Rodrigues, Nelson B;
- Chen-Li, David;
- Di Vincenzo, Joshua D;
- Juneja, Ashwin;
- Pinder, Benjamin D;
- McIntyre, Roger S;
- Rosenblat, Joshua D
Publication type:
Article
Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 382, doi. 10.1177/02698811241238283
By:
- Jameson, Adam;
- Faisal, Muhammad;
- Fylan, Beth;
- Bristow, Greg C;
- Sohal, Jaspreet;
- Dalton, Caroline;
- Sagoo, Gurdeep S;
- Cardno, Alastair G;
- McLean, Samantha L
Publication type:
Article
Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 362, doi. 10.1177/02698811241237869
By:
- Macoveanu, Julian;
- Petersen, Jeff Zarp;
- Mariegaard, Johanna;
- Jespersen, Andreas Elleby;
- Cramer, Katrine;
- Bruun, Caroline Fussing;
- Madsen, Helle Østergaard;
- Jørgensen, Martin Balslev;
- Vinberg, Maj;
- Fisher, Patrick M;
- Knudsen, Gitte Moos;
- Hageman, Ida;
- Ehrenreich, Hannelore;
- Kessing, Lars Vedel;
- Miskowiak, Kamilla Woznica
Publication type:
Article
Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use.
Published in:
Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 395, doi. 10.1177/02698811241237868
By:
- Papic, Ivan;
- Bistrovic, Petra;
- Krecak, Ivan;
- Ortner Hadziabdic, Maja;
- Lucijanic, Marko
Publication type:
Article